Case Report: Abemaciclib‐Induced Chronic Renal Failure
ABSTRACT Abemaciclib, a cyclin‐dependent kinase 4/6 inhibitor, may induce kidney damage during the treatment of hormone receptor‐positive/human epidermal growth factor receptor 2‐negative breast cancer. We report a case of a 52‐year‐old woman with normal baseline kidney function (serum creatinine, 6...
Saved in:
Main Authors: | Lu Lin, Jinhui Chen, Jing Li, Shuangxin Liu, Weihua Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-06-01
|
Series: | Medicine Advances |
Subjects: | |
Online Access: | https://doi.org/10.1002/med4.70017 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of hypertension, diabetes, and smoking on the levels of some biochemical parameters in chronic renal failure patients
by: Noor H. Ali, et al.
Published: (2019-05-01) -
Serum Erythropoietin in Patients with Chronic Renal Failure in the Predialysis Stage
by: Adelaida Ruseva, et al.
Published: (2023-12-01) -
Anemia and Left Ventricular Hypertrophy in Chronic Renal Failure
by: Gergana Todorova, et al.
Published: (2022-11-01) -
Lercanidipine in patients with chronic renal failure: the ZAFRA Study
by: N. R. Robles, et al.
Published: (2010-08-01) -
CONCENTRIC MYOCARDIAL REMODELING IN CHRONIC RENAL FAILURE
by: G. V. Volgina, et al.
Published: (2001-10-01)